Esperion Therapeutics
ESPR
#6296
Rank
S$1.08 B
Marketcap
S$4.52
Share price
4.87%
Change (1 day)
82.62%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: S$1.08 Billion

As of February 2026 Esperion Therapeutics has a market cap of S$1.08 Billion. This makes Esperion Therapeutics the world's 6296th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.08 B-12.07%
2025S$1.22 B101.37%
2024S$0.61 B35.98%
2023S$0.44 B-27.03%
2022S$0.61 B49.49%
2021S$0.41 B-53.82%
2020S$0.89 B-59.68%
2019S$2.21 B31.14%
2018S$1.68 B-26.93%
2017S$2.30 B464.5%
2016S$0.40 B-42.36%
2015S$0.70 B-34.78%
2014S$1.08 B307.05%
2013S$0.26 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Esperion Therapeutics was reported to be:

S$1.03 Billion
by Nasdaq info icon info icon
S$1.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$191.28 B 17,591.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$101.56 B 9,293.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$3.01 B 179.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.56 B-47.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.70 B 427.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$14.27 B 1,220.25%๐Ÿ‡บ๐Ÿ‡ธ USA